Observational Study of MIRCERA in Users of Self-Application and Multidose Systems

This non-interventional, observational study investigates the efficiency, safety and acceptance of MIRCERA in participants, who received erythropoiesis stimulating agent (ESA) using a self-application system. For each participant, the investigator documents 9 months of treatment with Mircera with respect to efficacy, safety and acceptance.

Inclusion Criteria:

• Anemia caused by CKD only
• Life expectancy of more than (>) 9 months in the judgment of the attending physician
• Ferritin >200 micrograms per liter (mcg/L) in accordance with the relevant guidelines
• The time point of changing to Mircera was only 3 months ago at the longest

Exclusion Criteria:

N/A